What's Going On With Autonomix Medical Stock Monday?
What's Going On With Autonomix Medical Stock Monday?
Autonomix Medical, Inc. (NASDAQ:AMIX) shares are moving higher on Monday after the company announced it was granted a U.S. patent titled Systems and Methods for Treating Cancer and/or Augmenting Organ Function.
Autonomix 医疗公司（纳斯达克：AMIX）股票在周一上涨，此前该公司宣布获得了一项名为“治疗癌症和/或增强器官功能的系统和方法”的美国专利。
What To Know: The patent encompasses technology for systems, methods and devices designed to treat cancerous tumors and manage cancer-related pain through interventional techniques. The company is first focusing on developing its technology to treat pain associated with pancreatic cancer.
需要了解的是：该专利涵盖了旨在通过介入技术治疗癌症肿瘤和管理癌症相关疼痛的系统、方法和设备。公司首先专注于开发其技术以治疗与胰腺癌相关的疼痛。
In a previously conducted preclinical mouse study, the company demonstrated that targeted nerve ablation resulted in a statistically significant reduction of metastases and tumor mass. While Autonomix is currently conducting a human clinical trial focused on pain reduction using this technology, it plans to explore in future studies whether this ablation technology can also slow pancreatic cancer growth and metastasis.
在之前进行的临床前小鼠研究中，该公司证明了靶向神经消融能显著减少转移和肿瘤质量。虽然Autonomix当前正在进行一项人体临床试验，重点是使用该技术减轻疼痛，但它计划在未来的研究中探讨这种消融技术是否也能减缓胰腺癌的生长和转移。
Related Link: Why Is White Label Technology Company SMX Stock Surging On Monday?
相关链接：为什么白标科技公司SMX股票在周一激增？
AMIX Price Action: At the time of publication, Autonomix stock is trading 18.8% higher at $3.92, according to data from Benzinga Pro.
AMIX价格动态：在发布时，根据Benzinga Pro的数据，Autonomix股票上涨18.8%，报$3.92。
Image: Image: Akava Photo from Pixabay
图片：来自Pixabay的Akava照片
